BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21206133)

  • 21. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.
    Varma MV; Rotter CJ; Chupka J; Whalen KM; Duignan DB; Feng B; Litchfield J; Goosen TC; El-Kattan AF
    Mol Pharm; 2011 Aug; 8(4):1303-13. PubMed ID: 21710988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta.
    Tupova L; Hirschmugl B; Sucha S; Pilarova V; Székely V; Bakos É; Novakova L; Özvegy-Laczka C; Wadsack C; Ceckova M
    Biomed Pharmacother; 2020 Sep; 129():110506. PubMed ID: 32768979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol.
    Kato Y; Miyazaki T; Kano T; Sugiura T; Kubo Y; Tsuji A
    J Pharm Sci; 2009 Jul; 98(7):2529-39. PubMed ID: 19067419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
    de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
    J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine decreased plasma exposure of glyburide partly via inhibiting intestinal absorption in rats.
    Jiang S; Zhao W; Chen Y; Zhong Z; Zhang M; Li F; Xu P; Zhao K; Li Y; Liu L; Liu X
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):240-6. PubMed ID: 25890690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of organic anion transporting polypeptide 1a5 (Oatp1a5) in the intestinal absorption of endothelin receptor antagonist in rats.
    Tani T; Gram LK; Arakawa H; Kikuchi A; Chiba M; Ishii Y; Steffansen B; Tamai I
    Pharm Res; 2008 May; 25(5):1085-91. PubMed ID: 17957449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of Olmesartan to Olmesartan Medoxomil, A Prodrug that Improves Intestinal Absorption, Confers Substrate Recognition by OATP2B1.
    Fukazawa N; Nishimura T; Orii K; Noguchi S; Tomi M
    Pharm Res; 2024 May; 41(5):849-861. PubMed ID: 38485855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.
    Kis O; Zastre JA; Hoque MT; Walmsley SL; Bendayan R
    Pharm Res; 2013 Apr; 30(4):1050-64. PubMed ID: 23224979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey.
    Kosa RE; Lazzaro S; Bi YA; Tierney B; Gates D; Modi S; Costales C; Rodrigues AD; Tremaine LM; Varma MV
    Drug Metab Dispos; 2018 Aug; 46(8):1179-1189. PubMed ID: 29880631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of [
    Yagi Y; Kimura H; Okuda H; Ono M; Nakamoto Y; Togashi K; Saji H
    Nucl Med Biol; 2019; 74-75():25-31. PubMed ID: 31450072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-incubation with cyclosporine A potentiates its inhibitory effects on pitavastatin uptake mediated by recombinantly expressed cynomolgus monkey hepatic organic anion transporting polypeptide.
    Takahashi T; Ohtsuka T; Uno Y; Utoh M; Yamazaki H; Kume T
    Biopharm Drug Dispos; 2016 Nov; 37(8):479-490. PubMed ID: 27603548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
    Iwai M; Minematsu T; Li Q; Iwatsubo T; Usui T
    Drug Metab Dispos; 2011 Dec; 39(12):2314-20. PubMed ID: 21918035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport characteristics of fexofenadine in the Caco-2 cell model.
    Petri N; Tannergren C; Rungstad D; Lennernäs H
    Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H
    Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
    Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
    J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H; Ohnishi A; Matsuo H; Sawada Y
    Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.
    Yamazaki M; Li B; Louie SW; Pudvah NT; Stocco R; Wong W; Abramovitz M; Demartis A; Laufer R; Hochman JH; Prueksaritanont T; Lin JH
    Xenobiotica; 2005 Jul; 35(7):737-53. PubMed ID: 16316932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein.
    Naruhashi K; Tamai I; Inoue N; Muraoka H; Sai Y; Suzuki N; Tsuji A
    J Pharm Pharmacol; 2001 May; 53(5):699-709. PubMed ID: 11370709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype.
    Beumer JH; Buckle T; Ouwehand M; Franke NE; Lopez-Lazaro L; Schellens JH; Beijnen JH; van Tellingen O
    Invest New Drugs; 2007 Feb; 25(1):1-7. PubMed ID: 16633714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.